Technology | August 03, 2008

Low Energy Beam Delivers High-Dose

Intrabeam is a miniature radiation source that delivers high-dose, yet is a low energy X-ray used for breast cancer therapy, neurosurgery and other radiation therapies developed by Carl Zeiss Meditec.

The Intrabeam System can be used to treat early stage breast cancer. The radiation dose is administrated to the tumor bed in the operating room, following lumpectomy.

As a minimally invasive technique for stereotactic treatment delivery, following biopsy, the X-ray source probe directs the energy to the target, delivering the dose to the center of the tumor thereby minimizing radiation to healthy tissues.

During treatment delivery, an isotropic dose can be applied directly to the tumor bed, sparing healthy tissue and critical structures, which is said to maximize the amount of dose delivered to the target.

With the precision and control of brachytherapy and the flexibility of intraoperative treatment delivery, Intrabeam offers more options. The miniature X-ray source delivers up to 50kV of energy to the target tissue. Steep dose fall-off ensures that most of the dose stays in the target tissue. Spherical dose delivery that is safely and reliably delivered to tumors and tumor beds. Minimal shielding requirements mean safety for the patient and personnel. Typical treatment takes less than thirty minutes.

This high dose, low energy X-ray requires, according to the manufacturer, minimal shielding for personnel in the operating room, and there is no need to stand behind concrete walls or heavy beam-stopping equipment.

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
Overlay Init